1 line
40 KiB
Plaintext
1 line
40 KiB
Plaintext
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,21]],"date-time":"2024-01-21T12:57:46Z","timestamp":1705841866005},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T00:00:00Z","timestamp":1682553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n <jats:p>Sudden cardiac death and ventricular arrhythmias are a global health issue. Recently, a new guideline for the management of ventricular arrhythmias and prevention of sudden cardiac death has been published by the European Society of Cardiology that serves as an update to the 2015 guideline on this topic. This review focuses on 10 novel key aspects of the current guideline: As new aspects, public basic life support and access to defibrillators are guideline topics. Recommendations for the diagnostic evaluation of patients with ventricular arrhythmias are structured according to frequently encountered clinical scenarios. Management of electrical storm has become a new focus. In addition, genetic testing and cardiac magnetic resonance imaging significantly gained relevance for both diagnostic evaluation and risk stratification. New algorithms for antiarrhythmic drug therapy aim at improving safe drug use. The new recommendations reflect increasing relevance of catheter ablation of ventricular arrhythmias, especially in patients without structural heart disease or stable coronary artery disease with only mildly impaired ejection fraction and haemodynamically tolerated ventricular tachycardias. Regarding sudden cardiac death risk stratification, risk calculators for laminopathies, and long QT syndrome are now considered besides the already established risk calculator for hypertrophic cardiomyopathy. Generally, \u2018new\u2019 risk markers beyond left ventricular ejection fraction are increasingly considered for recommendations on primary preventive implantable cardioverter defibrillator therapy. Furthermore, new recommendations for diagnosis of Brugada syndrome and management of primary electrical disease have been included. With many comprehensive flowcharts and practical algorithms, the new guideline takes a step towards a user-oriented reference book.<\/jats:p>","DOI":"10.1093\/europace\/euad091","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T07:34:50Z","timestamp":1682580890000},"source":"Crossref","is-referenced-by-count":14,"title":["Spotlight on the 2022 ESC guideline management of ventricular arrhythmias and prevention of sudden cardiac death: 10 novel key aspects"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"http:\/\/orcid.org\/0000-0002-9812-5519","authenticated-orcid":false,"given":"Hilke","family":"K\u00f6nemann","sequence":"first","affiliation":[{"name":"Department of Cardiology II: Electrophysiology, University Hospital M\u00fcnster , Albert-Schweitzer Campus 1, 48149 M\u00fcnster , Germany"}]},{"ORCID":"http:\/\/orcid.org\/0000-0003-0323-4956","authenticated-orcid":false,"given":"Nikolaos","family":"Dagres","sequence":"additional","affiliation":[{"name":"Department of Cardiac Electrophysiology, Heart Center Leipzig at University of Leipzig , Leipzig , Germany"}]},{"ORCID":"http:\/\/orcid.org\/0000-0002-1737-1903","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Merino","sequence":"additional","affiliation":[{"name":"Cardiology Department, La Paz University Hospital , Madrid , Spain"}]},{"ORCID":"http:\/\/orcid.org\/0000-0001-8428-7050","authenticated-orcid":false,"given":"Christian","family":"Sticherling","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Basel , Basel , Switzerland"}]},{"ORCID":"http:\/\/orcid.org\/0000-0001-6645-082X","authenticated-orcid":false,"given":"Katja","family":"Zeppenfeld","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Leiden University Medical Centre , Leiden , The Netherlands"}]},{"ORCID":"http:\/\/orcid.org\/0000-0003-3895-9316","authenticated-orcid":false,"given":"Jacob","family":"Tfelt-Hansen","sequence":"additional","affiliation":[{"name":"Section of Genetics, Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen , Copenhagen , Denmark"},{"name":"The Department of Cardiology, The Heart Centre, Copenhagen University Hospital, Rigshospitalet , Copenhagen , Denmark"}]},{"ORCID":"http:\/\/orcid.org\/0000-0002-3735-8503","authenticated-orcid":false,"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[{"name":"Department of Cardiology II: Electrophysiology, University Hospital M\u00fcnster , Albert-Schweitzer Campus 1, 48149 M\u00fcnster , Germany"}]}],"member":"286","published-online":{"date-parts":[[2023,4,27]]},"reference":[{"key":"2023053015032335400_euad091-B1","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0735-1097(97)00355-0","article-title":"out-of-hospital cardiac arrest in the 1990\u2019s: a population-based study in the maastricht area on incidence, characteristics and survival","volume":"30","author":"de Vreede-Swagemakers","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.hrthm.2021.05.005","article-title":"Nationwide burden of sudden cardiac death: a study of 54,028 deaths in Denmark","volume":"18","author":"Lynge","year":"2021","journal-title":"Heart Rhythm"},{"key":"2023053015032335400_euad091-B3","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B4","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.resuscitation.2017.12.011","article-title":"Determinants of occurrence and survival after sudden cardiac arrest-a European perspective: the ESCAPE-NET project","volume":"124","author":"Empana","year":"2018","journal-title":"Resuscitation"},{"key":"2023053015032335400_euad091-B6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.resuscitation.2005.03.021","article-title":"Incidence of EMS-treated out-of-hospital cardiac arrest in Europe","volume":"67","author":"Atwood","year":"2005","journal-title":"Resuscitation"},{"key":"2023053015032335400_euad091-B7","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jacc.2022.02.041","article-title":"Incidence of sudden cardiac death in the European Union","volume":"79","author":"Empana","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13054-020-2773-2","article-title":"The global survival rate among adult out-of-hospital cardiac arrest patients who received cardiopulmonary resuscitation: a systematic review and meta-analysis","volume":"24","author":"Yan","year":"2020","journal-title":"Critical care"},{"key":"2023053015032335400_euad091-B9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.resuscitation.2021.02.007","article-title":"European resuscitation council guidelines 2021: epidemiology of cardiac arrest in Europe","volume":"161","author":"Gr\u00e4sner","year":"2021","journal-title":"Resuscitation"},{"key":"2023053015032335400_euad091-B10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMoa040566","article-title":"Public-access defibrillation and survival after out-of-hospital cardiac arrest","volume":"351","author":"Hallstrom","year":"2004","journal-title":"N Engl J Med"},{"key":"2023053015032335400_euad091-B11","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa1601891","article-title":"Bystander efforts and 1-year outcomes in out-of-hospital cardiac arrest","volume":"376","author":"Kragholm","year":"2017","journal-title":"N Engl J Med"},{"key":"2023053015032335400_euad091-B12","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(19)32488-2","article-title":"Public-access defibrillation and neurological outcomes in patients with out-of-hospital cardiac arrest in Japan: a population-based cohort study","volume":"394","author":"Nakashima","year":"2019","journal-title":"Lancet"},{"key":"2023053015032335400_euad091-B13","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.117.030700","article-title":"Impact of bystander automated external defibrillator use on survival and functional outcomes in shockable observed public cardiac arrests","volume":"137","author":"Pollack","year":"2018","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijcard.2017.11.077","article-title":"Significant impact of electrical storm on mortality in patients with structural heart disease and an implantable cardiac defibrillator","volume":"255","author":"Noda","year":"2018","journal-title":"Int J Cardiol"},{"key":"2023053015032335400_euad091-B15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eut304","article-title":"Role of electrical storm as a mortality and morbidity risk factor and its clinical predictors: a meta-analysis","volume":"16","author":"Guerra","year":"2014","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B16","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/europace\/euac078","article-title":"Outcomes following cardiac sympathetic denervation in patients with structural heart disease and refractory ventricular arrhythmia","volume":"24","author":"K\u00f6nig","year":"2022","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B17","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B18","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.117.031947","article-title":"RBM20 mutations induce an arrhythmogenic dilated cardiomyopathy related to disturbed calcium handling","volume":"138","author":"van den Hoogenhof","year":"2018","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B19","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic risk of arrhythmic phenotypes in patients with dilated cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ehf2.13100","article-title":"Differences between familial and sporadic dilated cardiomyopathy: ESC EORP cardiomyopathy & myocarditis registry","volume":"8","author":"Asselbergs","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2023053015032335400_euad091-B21","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B23","first-page":"e558","article-title":"2020 AHA\/ACC Guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B24","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jacc.2020.02.033","article-title":"Natural history and risk stratification in Andersen-tawil syndrome type 1","volume":"75","author":"Mazzanti","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B25","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1161\/CIRCULATIONAHA.117.027983","article-title":"Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome: a Japanese multicenter registry","volume":"135","author":"Yamagata","year":"2017","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B26","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jacc.2013.09.078","article-title":"Novel insight into the natural history of short QT syndrome","volume":"63","author":"Mazzanti","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B27","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euac053.011","article-title":"Genetics of idiopathic ventricular fibrillation","volume":"24","author":"Pannone","year":"2022","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B28","doi-asserted-by":"publisher","article-title":"Outcome of patients with idiopathic ventricular fibrillation and correlation with ECG markers of early repolarization","author":"Rath","year":"2022","journal-title":"Clin Res Cardiol","DOI":"10.1007\/s00392-022-02125-9"},{"key":"2023053015032335400_euad091-B29","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa1510687","article-title":"A prospective study of sudden cardiac death among children and young adults","volume":"374","author":"Bagnall","year":"2016","journal-title":"N Engl J Med"},{"key":"2023053015032335400_euad091-B30","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.jacc.2017.02.046","article-title":"Utility of post-mortem genetic testing in cases of sudden arrhythmic death syndrome","volume":"69","author":"Lahrouchi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B31","first-page":"1383","article-title":"Diagnostic yield in sudden unexplained death and aborted cardiac arrest in the young: the experience of a tertiary referral center in The Netherlands","volume-title":"Heart Rhythm","author":"van der Werf","year":"2010"},{"key":"2023053015032335400_euad091-B32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/cge.12126","article-title":"High prevalence of genetic variants previously associated with Brugada syndrome in new exome data","volume":"84","author":"Risgaard","year":"2013","journal-title":"Clin Genet"},{"key":"2023053015032335400_euad091-B33","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/CIRCULATIONAHA.120.047640","article-title":"Prognostic value of nonischemic ringlike left ventricular scar in patients with apparently idiopathic nonsustained ventricular arrhythmias","volume":"143","author":"Muser","year":"2021","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B34","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1161\/CIRCEP.113.001172","article-title":"Prevalence and prognostic value of concealed structural abnormalities in patients with apparently idiopathic ventricular arrhythmias of left versus right ventricular origin: a magnetic resonance imaging study","volume":"7","author":"Nucifora","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023053015032335400_euad091-B35","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.006709","article-title":"Diagnosis and prognosis in sudden cardiac arrest survivors without coronary artery disease: utility of a clinical approach using cardiac magnetic resonance imaging","volume":"10","author":"Rodrigues","year":"2017","journal-title":"Circ Cardiovasc Imaging"},{"key":"2023053015032335400_euad091-B36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCULATIONAHA.109.853143","article-title":"Systematic assessment of patients with unexplained cardiac arrest: cardiac arrest survivors with preserved ejection fraction registry (CASPER)","volume":"120","author":"Krahn","year":"2009","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/eurheartj\/ehn219","article-title":"Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families","volume":"29","author":"Behr","year":"2008","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/europace\/euaa106","article-title":"Recommendations for participation in leisure-time physical activity and competitive sports of patients with arrhythmias and potentially arrhythmogenic conditions. Part 2: ventricular arrhythmias, channelopathies, and implantable defibrillators","volume":"23","author":"Heidbuchel","year":"2021","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B39","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.amjcard.2016.08.056","article-title":"Usefulness of combined functional assessment by cardiac magnetic resonance and tissue characterization versus task force criteria for diagnosis of arrhythmogenic right ventricular cardiomyopathy","volume":"118","author":"Aquaro","year":"2016","journal-title":"Am J Cardiol"},{"key":"2023053015032335400_euad091-B40","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.jacc.2012.11.087","article-title":"Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"te Riele","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.hrthm.2020.08.009","article-title":"Primary prevention implantable cardioverter-defibrillators in hypertrophic cardiomyopathy-are there predictors of appropriate therapy?","volume":"18","author":"Weissler-Snir","year":"2021","journal-title":"Heart Rhythm"},{"key":"2023053015032335400_euad091-B42","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jchf.2016.09.017","article-title":"Late gadolinium enhancement and the risk for ventricular arrhythmias or sudden death in dilated cardiomyopathy: systematic review and meta-analysis","volume":"5","author":"Di Marco","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2023053015032335400_euad091-B44","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1161\/CIRCULATIONAHA.120.048477","article-title":"Relationship of LVEF and myocardial scar to long-term mortality risk and mode of death in patients with nonischemic cardiomyopathy","volume":"143","author":"Klem","year":"2021","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B45","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2010.03.087","article-title":"Cardiac magnetic resonance predicts outcome in patients with premature ventricular complexes of left bundle branch block morphology","volume":"56","author":"Aquaro","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B46","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.hrthm.2017.06.040","article-title":"Value of cardiac magnetic resonance imaging and programmed ventricular stimulation in patients with frequent premature ventricular complexes undergoing radiofrequency ablation","volume":"14","author":"Yokokawa","year":"2017","journal-title":"Heart Rhythm"},{"key":"2023053015032335400_euad091-B47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2012.10.019","article-title":"Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Dechering","year":"2013","journal-title":"Heart Rhythm"},{"key":"2023053015032335400_euad091-B48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrcardio.2015.110","article-title":"Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms","volume":"13","author":"Frommeyer","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"2023053015032335400_euad091-B49","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cardiores.2004.10.016","article-title":"Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3","volume":"65","author":"Milberg","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2023053015032335400_euad091-B50","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/eurjhf\/hfr107","article-title":"A new mechanism preventing proarrhythmia in chronic heart failure: rapid phase-III repolarization explains the low proarrhythmic potential of amiodarone in contrast to sotalol in a model of pacing-induced heart failure","volume":"13","author":"Frommeyer","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"2023053015032335400_euad091-B51","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/europace\/euaa288","article-title":"Role of the rabbit whole-heart model for electrophysiologic safety pharmacology of non-cardiovascular drugs","volume":"23","author":"Ellermann","year":"2021","journal-title":"EP Europace"},{"key":"2023053015032335400_euad091-B52","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","author":"Cardiac Arrhythmia Suppression Trial (CAST) Investigators","year":"1989","journal-title":"N Engl J Med"},{"key":"2023053015032335400_euad091-B53","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2125.2008.03229.x","article-title":"Case ascertainment and estimated incidence of drug-induced long-QT syndrome: study in Southwest France","volume":"66","author":"Molokhia","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"2023053015032335400_euad091-B54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/europace\/eut214","article-title":"Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany","volume":"16","author":"Sarganas","year":"2014","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B55","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/europace\/euac146","article-title":"In-hospital mortality and major complications related to radiofrequency catheter ablations of over 10 000 supraventricular arrhythmias from 2005 to 2020: individualized case analysis of multicentric administrative data","volume":"25","author":"Doldi","year":"2023","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jacep.2015.04.005","article-title":"Multicenter outcomes for catheter ablation of idiopathic premature ventricular complexes","volume":"1","author":"Latchamsetty","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2023053015032335400_euad091-B57","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCEP.113.000805","article-title":"Radiofrequency ablation versus antiarrhythmic medication for treatment of ventricular premature beats from the right ventricular outflow tract: prospective randomized study","volume":"7","author":"Ling","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023053015032335400_euad091-B58","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1046\/j.1540-8167.2003.02180.x","article-title":"Endocardial mapping of right ventricular outflow tract tachycardia using noncontact activation mapping","volume":"14","author":"Ribbing","year":"2003","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023053015032335400_euad091-B59","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jacc.2013.06.012","article-title":"Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study","volume":"62","author":"Penela","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B60","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.hlc.2018.01.012","article-title":"Ventricular ectopy in the context of left ventricular systolic dysfunction: risk factors and outcomes following catheter ablation","volume":"28","author":"Lee","year":"2019","journal-title":"Heart Lung Circ"},{"key":"2023053015032335400_euad091-B61","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/europace\/euab274","article-title":"Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium","volume":"24","author":"Kahle","year":"2022","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B62","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.116.004549","article-title":"Fascicular ventricular tachycardia originating from papillary muscles: Purkinje network involvement in the reentrant circuit","volume":"10","author":"Komatsu","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023053015032335400_euad091-B63","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijcard.2013.09.008","article-title":"Idiopathic ventricular outflow tract arrhythmias from the great cardiac vein: challenges and risks of catheter ablation","volume":"169","author":"Steven","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023053015032335400_euad091-B64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1513614","article-title":"Ventricular tachycardia ablation versus escalation of antiarrhythmic drugs","volume":"375","author":"Sapp","year":"2016","journal-title":"N Engl J Med"},{"key":"2023053015032335400_euad091-B65","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/europace\/euab298","article-title":"Comparative effectiveness of ventricular tachycardia ablation vs. escalated antiarrhythmic drug therapy by location of myocardial infarction: a sub-study of the VANISH trial","volume":"24","author":"Samuel","year":"2022","journal-title":"EP Europace"},{"key":"2023053015032335400_euad091-B66","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.122.059598","article-title":"Does timing of ventricular tachycardia ablation affect prognosis in patients with an implantable cardioverter defibrillator? results from the multicenter Randomized PARTITA Trial","volume":"145","author":"Della Bella","year":"2022","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B67","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2022.01.050","article-title":"Substrate ablation vs antiarrhythmic drug therapy for symptomatic ventricular tachycardia","volume":"79","author":"Arenal","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B68","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCULATIONAHA.119.043400","article-title":"Preventive or deferred ablation of ventricular tachycardia in patients with ischemic cardiomyopathy and implantable defibrillator (BERLIN VT): a multicenter randomized trial","volume":"141","author":"Willems","year":"2020","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B69","author":"ClinicalTrials.gov"},{"key":"2023053015032335400_euad091-B70","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jacc.2022.06.035","article-title":"Clinical outcomes in patients with dilated cardiomyopathy and ventricular tachycardia","volume":"80","author":"Zeppenfeld","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B71","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/jce.12751","article-title":"Catheter ablation of ventricular tachycardia as the first-line therapy in patients with coronary artery disease and preserved left ventricular systolic function: long-term results","volume":"26","author":"Clemens","year":"2015","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2023053015032335400_euad091-B72","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/eurheartj\/ehu040","article-title":"Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%","volume":"35","author":"Maury","year":"2014","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B73","doi-asserted-by":"publisher","article-title":"Management of ventricular arrhythmias worldwide: comparison of the latest ESC, AHA\/ACC\/HRS, and CCS\/CHRS guidelines","author":"K\u00f6nemann","year":"2023","journal-title":"JACC Clin Electrophysiol","DOI":"10.1016\/j.jacep.2022.12.008"},{"key":"2023053015032335400_euad091-B74","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1053\/euhj.2000.2476","article-title":"Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study Hamburg. Canadian implantable defibrillator study","volume":"21","author":"Connolly","year":"2000","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B75","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1161\/01.CIR.0000088781.99943.95","article-title":"Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes","volume":"108","author":"Ha\u00efssaguerre","year":"2003","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B76","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.117.005053","article-title":"Electrical substrate elimination in 135 consecutive patients with Brugada syndrome","volume":"10","author":"Pappone","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2023053015032335400_euad091-B77","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCULATIONAHA.118.039022","article-title":"Mapping and ablation of ventricular fibrillation associated with early repolarization syndrome","volume":"140","author":"Nademanee","year":"2019","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B78","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N Engl J Med"},{"key":"2023053015032335400_euad091-B79","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0735-1097(96)00477-9","article-title":"High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias","volume":"29","author":"Link","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B80","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.jacc.2021.04.030","article-title":"Improved risk stratification for ventricular arrhythmias and sudden death in patients with nonischemic dilated cardiomyopathy","volume":"77","author":"Di Marco","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B81","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/01.CIR.0000143375.93288.82","article-title":"Natural history and risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"110","author":"Hulot","year":"2004","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B82","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCULATIONAHA.109.913871","article-title":"Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia","volume":"122","author":"Corrado","year":"2010","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B83","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjcard.2012.09.025","article-title":"Usefulness of inducible ventricular tachycardia to predict long-term adverse outcomes in arrhythmogenic right ventricular cardiomyopathy","volume":"111","author":"Saguner","year":"2013","journal-title":"Am J Cardiol"},{"key":"2023053015032335400_euad091-B84","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1016\/j.jacc.2016.09.951","article-title":"Arrhythmogenic right ventricular cardiomyopathy: clinical course and predictors of arrhythmic risk","volume":"68","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B85","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"O\u2019Mahony","year":"2014","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B86","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamacardio.2019.2861","article-title":"Development of a Novel risk prediction model for Sudden cardiac death in childhood hypertrophic cardiomyopathy (HCM risk-kids)","volume":"4","author":"Norrish","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2023053015032335400_euad091-B87","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/eurjpc\/zwab181","article-title":"External validation of the HCM risk-kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy","volume":"29","author":"Norrish","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023053015032335400_euad091-B88","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.118.039410","article-title":"Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies","volume":"140","author":"Wahbi","year":"2019","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B89","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMoa022147","article-title":"Risk stratification in the long-QT syndrome","volume":"348","author":"Priori","year":"2003","journal-title":"N Engl J Med"},{"key":"2023053015032335400_euad091-B90","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.jacc.2018.01.078","article-title":"Interplay between genetic substrate, QTc duration, and arrhythmia risk in patients with long QT syndrome","volume":"71","author":"Mazzanti","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B91","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/europace\/euab238","article-title":"Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)","volume":"24","author":"Mazzanti","year":"2022","journal-title":"Europace"},{"key":"2023053015032335400_euad091-B92","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.jacc.2012.07.046","article-title":"Not all beta-blockers are equal in the management of long QT syndrome types 1 and 2: higher recurrence of events under metoprolol","volume":"60","author":"Chockalingam","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B93","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"145","author":"Peltenburg","year":"2022","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B94","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jacc.2015.12.033","article-title":"gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3","volume":"67","author":"Mazzanti","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2023053015032335400_euad091-B95","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/europace\/euq517","article-title":"Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature","volume":"13","author":"Pott","year":"2011","journal-title":"EP Europace"},{"key":"2023053015032335400_euad091-B96","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCULATIONAHA.115.017885","article-title":"Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis","volume":"133","author":"Sroubek","year":"2016","journal-title":"Circulation"},{"key":"2023053015032335400_euad091-B97","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1093\/eurheartj\/ehm116","article-title":"Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data","volume":"28","author":"Paul","year":"2007","journal-title":"Eur Heart J"},{"key":"2023053015032335400_euad091-B98","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/heartjnl-2020-318881","article-title":"Temporal trends and sex differences in sudden cardiac death in the Copenhagen city heart study","volume":"107","author":"\u00c5gesen","year":"2021","journal-title":"Heart"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/5\/euad091\/50487370\/euad091.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/25\/5\/euad091\/50487370\/euad091.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T15:06:51Z","timestamp":1685459211000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euad091\/7143805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,27]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5,19]]}},"URL":"http:\/\/dx.doi.org\/10.1093\/europace\/euad091","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":["Physiology (medical)","Cardiology and Cardiovascular Medicine"],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,4,27]]}}} |